Top 10 Diversified Bank Companies To Own For 2014

LONDON: I believe that giant commodities trader�Glencore International� (LSE: GLEN  ) and mining leviathan�Xstrata� (LSE: XTA  ) are well-positioned to tread higher now that their protracted merger has received final approval.

Commodity prices remain extremely volatile given enduring uncertainty surrounding the macroeconomic environment, as recent swings in the gold price has demonstrated. Meanwhile, a number of metals markets are also facing the prospect of worsening oversupply in coming years, threatening the profitability of mining companies across the globe.

Despite this, I reckon that the tie-up between the two firms -- which is set for completion next month -- should yield exciting returns for investors, as cash flow balloons and earnings look set to march higher.

Company tie-up given final green light
Earlier this month, the companies received approval from China's regulator, MOFCOM, to complete their protracted tie-up that dates back to February 2012, with the sales process required to get under way within three months from mid-April. Glencore is expected to pay in the region of $30bn to complete the deal.

Top Beverage Companies To Own In Right Now: CEL-SCI Corp (CVM)

CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Multikine

CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.

New Manufacturing Facility

CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.

LEAPS

CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.

Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.

Advisors' Opinion:

• [By James E. Brumley]

  Little TNI Biotech Inc. (OTCMKTS:TNIB) just gave bigger immunology players like Amgen, Inc. (NASDAQ:AMGN) or CEL-SCI Corporation (NYSEMKT:CVM) a new reason to worry. Though CVM and AMGN aren't exactly sweating bullets yet, TNIB has taken not a big step forward in terms biotechnological progress, but rather, has widened its net with a lateral expansion.

• [By Bryan Murphy]

  Look out AbbVie Inc. (NYSE:ABBV), and Gilead Sciences, Inc. (NASDAQ:GILD), you may want to look over your shoulder as well. There's a new immunology player coming to town, and its name is CEL-SCI Corporation (NYSEMKT:CVM). Yes, AbbVie may be the name behind blockbuster drug Humira - with nearly $10 billion in sales in 2012 - while Gilead Sciences is saving HIV patients' lives with immunological therapies Stribild and Complera. But, small cap company CEL-SCI may be closer to launching its own immunology drug sooner than most investors realize.

Top 10 Diversified Bank Companies To Own For 2014: SMART Technologies Inc.(SMT)

SMART Technologies Inc. designs, develops, and sells interactive technology products and solutions that enhance learning and enable people to collaborate worldwide. The company offers a range of SMART Board interactive whiteboards and displays, as well as other interactive products, such as interactive tables, interactive pen displays, student response systems, wireless slates, audio enhancement systems, document cameras, conferencing software, and a line of interactive learning software. Its portfolio of related attachment products include SMART Response, SMART Slate, SMART Document Camera, SMART Table, SMART Audio, and SMART Classroom Suite. SMART Technologies also provides free online learning resources, an online teacher community, and training and professional development. It sells its interactive whiteboards through a network of distributors and dealers to the education, business, and government markets. The company was founded in 1987 and is headquartered in Calgary , Canada.

Advisors' Opinion:

• [By Michael Robinson]

  Smart Technologies (SMT)

  Smart Technologies is a company that literally lives up to its name. It's a supplier of interactive education tools, used by more than 40 million students, in more than 175 countries.

Top 10 Diversified Bank Companies To Own For 2014: Royal Caribbean Cruises Ltd.(RCL)

Royal Caribbean Cruises Ltd. operates in the cruise vacation industry worldwide. It owns five cruise brands, which comprise Royal Caribbean International, Celebrity Cruises, Pullmantur, Azamara Club Cruises, and CDF Croisi�es de France. The Royal Caribbean International brand provides various itineraries and cruise lengths with options for onboard dining, entertainment, and other onboard activities primarily for the contemporary segment. It offers surf simulators, water parks, ice skating rinks, rock climbing walls, and shore excursions at each port of call, as well as boulevards with shopping, dining, and entertainment venues. The Celebrity Cruises brand operates onboard upscale ships that offer luxurious accommodations, fine dining, personalized services, spa facilities, venue featuring live grass, and glass blowing studio for the premium segment, as well as resells computers and other media devices. The Pullmantur brand provides an array of onboard activities and serv ices to guests, including exercise facilities, swimming pools, beauty salons, gaming facilities, shopping, dining, complimentary beverages, and entertainment venues serving the contemporary segment of the Spanish, Portuguese, and Latin American cruise markets. The Azamara Club Cruises brand offers various onboard services, amenities, gaming facilities, fine dining, spa and wellness, butler service for suites, and interactive entertainment venues for the up-market segment of the North American, United Kingdom, German, and Australian markets. The CDF Croisieres de France brand offers seasonal itineraries to the Mediterranean; and various onboard services, amenities, entertainment venues, exercise and spa facilities, fine dining, and gaming facilities for the contemporary segment of the French cruise market. As of December 31, 2011, the company operated 39 ships with a total capacity of approximately 92,650 berths. Royal Caribbean Cruises Ltd. was founded in 1968 and is headqua rtered in Miami, Florida.

Advisors' Opinion:

• [By Rick Munarriz]

  Carnival stock is trading closer to its 52-week low than its high, and the same can't be said of rivals Royal Caribbean (NYSE: RCL  ) and NCL (NYSE: NCL  ) .�

Top 10 Diversified Bank Companies To Own For 2014: IMAX Corp (IMAX)

IMAX Corporation, incorporated on January 1, 2002, together with its wholly owned subsidiaries, is an entertainment technology companies, specializing in motion picture technologies and presentations. The Company�� customers who purchase lease or otherwise acquire the IMAX theatre systems are theatre exhibitors, which operate commercial theatres, museums, science centers, and destination entertainment sites. IMAX theatre systems combine the Company�� digital re-mastering movie conversion technology (IMAX DMR), projectors with equipment and automated theatre control systems, sound system components, screens, theatre geometry, and theatre acoustics.

The Company�� principal business is the design, manufacture and delivery of theater systems (IMAX theater systems). The Company�� customers who purchase, lease or otherwise acquire the IMAX theater systems through joint revenue sharing arrangements are theater exhibitors that operate commercial theaters (particularly multiplexes), museums, science centers, or destination entertainment sites. The Company does not own IMAX theaters, but licenses the use of its trademarks along with the sale, lease or contribution of the IMAX theater system.

IMAX Systems, Theater System Maintenance and Joint Revenue Sharing Arrangements

The Company provides IMAX theater systems to customers on a sales or long-term lease basis with an initial 10-year term. These agreements consist of initial fees and ongoing fees (which can include a fixed minimum amount per annum and contingent fees in excess of the minimum payments) and maintenance and extended warranty fees. The initial fees vary depending on the system configuration and location of the theater and generally are paid to the Company in installments between the time of system signing and the time of system installation. Ongoing fees are paid over the term of the contract, commencing after the theater system has been installed and are generally equal to the greater of a fixed minimu! m amount per annum or a percentage of boxoffice receipts. The Company also provides IMAX theater systems to customers under joint revenue sharing arrangements, pursuant to which the Company provides the IMAX theater system in return for a portion of the customer�� IMAX box-office receipts, and in some cases concession revenues and/or a small upfront or initial payment. As at December 31, 2012, the Company had 316 theaters in operation under joint revenue sharing arrangements.

Production and Digital Re-Mastering (IMAX DMR)

The Company�� technology digitally re-masters Hollywood films into IMAX digital cinema package format or 15/70-format film. IMAX DMR digitally enhances the image resolution of motion picture films for projection on IMAX screens while maintaining or enhancing the visual clarity and sound quality to levels for which The IMAX Experience is known. This technology enabled the IMAX theater network to release Hollywood films simultaneously with domestic release. In a typical IMAX DMR film arrangement, the Company will receive a percentage of net box-office receipts of any commercial films released in the IMAX network, which is generally 10-15%, from a film studio for the conversion of the film to the IMAX DMR format and access to its distribution platform. During the year ended December 31, 2012, 35 films converted through the IMAX DMR process were released to theaters within the IMAX network. As of December 31, 2012, the Company released 23 IMAX DMR titles to theaters within the IMAX network. During 2012, five local language IMAX DMR films were released, including one French film, Houba! On the Trail of the Marsupilami: The IMAX Experience and four Chinese IMAX DMR titles: Tai Chi 0: An IMAX 3D Experience, Tai Chi Hero: An IMAX 3D Experience, Back to 1942: The IMAX Experience and CZ12: The IMAX Experience.

Film Distribution and Post-Production

The Company is also a distributor of large-format films, primarily catering to its institution! al theate! r partners. The Company generally distributes films, which it produces or for which it has acquired distribution rights from independent producers. The Company generally receives a percentage of the theater box-office receipts as a distribution fee. Films produced by the Company are typically financed through third parties, whereby the Company will generally receive a film production fee in exchange for producing the film and a distribution fee for distributing the film. The Company utilizes third-party funding for the majority of original films it produces and distributes. In 2012, the Company, along with Warner Bros. Pictures (WB) and MacGillivray Freeman Films (MFF) released an original title, To the Artic 3D: An IMAX 3D Experience.

The Company derives a small portion of its revenues from other sources. As of December 31, 2012, the Company had four owned and operated theaters. In addition, the Company has a commercial arrangement with one theater resulting in the sharing of profits and losses and provides management services to two theaters. The Company also rents its two dimensional (2D) and three dimensional (3D) large-format film and digital cameras to third party production companies. The Company maintains cameras and other film equipment and also offers production advice and technical assistance to both documentary and Hollywood filmmakers. Additionally, the Company generates revenues from the sale of after-market parts and 3D glasses. As of December 31, 2012, approximately 54.2% of IMAX systems in operation were located in the United States and Canada. As at December 31, 2012, approximately 45.8% of IMAX systems in operation were located within international markets (other than the United States and Canada).

Advisors' Opinion:

• [By Dan Caplinger]

  The main rival that RealD faces is IMAX (NYSE: IMAX  ) , and the biggest challenge IMAX poses for RealD is that IMAX and its huge-screen theaters give viewers an impressive experience even with 2-D films. That flexibility has been a key component driving IMAX's growth, with a global footprint extending to hundreds of theaters in more than 50 countries worldwide. RealD has tried to match that with its precision white-screen technology, but RealD can't make theater-operators install the huge screens to match up to IMAX.

• [By Rick Munarriz]

  IMAX (NYSE: IMAX  ) has played a major part in beefing up box-office receipts in recent years. Patrons are willfully paying a few bucks more to screen new releases in IMAX's enhanced screenings, and that's good news for exhibitors, movie studios, and IMAX.

• [By John Udovich]

  The shares of small cap IMAX Corporation (NYSE: IMAX) have slipped more than 10% this week on growth concerns - meaning it might be a good idea to take a closer look at the stock plus its performance�verses other cinema stocks like Carmike Cinemas, Inc (NASDAQ: CKEC), Cinemark Holdings, Inc (NYSE: CNK) and Regal Entertainment Group (NYSE: RGC) along with the PowerShares Dynamic Leisure & Entertainment ETF�(NYSEARCA: PEJ).

• [By Rich Smith]

  On Monday, Mississauga, Ontario-based IMAX (NYSE: IMAX  ) announced that it has signed an agreement to install five IMAX theatres at existing Mexican multiplexes operated by Cinepolis. The agreement, once implemented, will give IMAX a total of 12 Cinepolis locations in Mexico, in addition to the one now operating in Brazil.

Top 10 Diversified Bank Companies To Own For 2014: Fresenius Medical Care Corporation (FMS)

Fresenius Medical Care AG & Co. KGaA, a dialysis company, provides products and services for patients with chronic kidney diseases. As of May 12, 2011, it provided dialysis care services to 216,942 patients through its network of 2,769 dialysis clinics primarily in North America, Europe, Latin America, the Asia-Pacific, and Africa. The company also develops and manufactures various dialysis products, including hemodialysis machines, dialyzers, hemofilters, dialysis fluid filters, tubing systems, fistula needles, dialysis related equipment, acute hemodialysis machines, plasma filters, acute tubing systems and cassettes, catheters, and related disposable products for chronic hemodialysis, acute therapy, home therapy, and therapeutic apheresis, as well as dialysis drugs. In addition, it provides laboratory services. Fresenius Medical sells its products through distributors. The company was founded in 1996 and is headquartered in Bad Homburg, Germany.

Advisors' Opinion:

• [By Johanna Bennett]

  The Centers for Medicare and Medicaid decided today to cut government payment to dialysis clinics. So why did share prices for DaVita HealthCare Partners (DVA) and rival Fresenius Medical Care (FMS) rise so steeply today?

• [By Ben Eisen]

  DaVita (DVA) �gained 8.9% and Fresenius (FMS) �rose 7.2%.

• [By Louie Grint]

  Still unaffected
  First, Fresenius Medical Care (NYSE: FMS  ) is the No. 1 global provider of dialysis equipment. It enjoys leading market share of almost 33% in its home country.

Top 10 Diversified Bank Companies To Own For 2014: ING Prime Rate Trust (PPR)

ING Prime Rate Trust (the Trust) is a diversified closed-end management investment company. The Trust seeks to provide a high a level of current income together with the preservation of capital. It invests least 80% of its net assets, plus the amount of any borrowings for investment purposes, in United States dollar-denominated, floating-rate secured senior loans. It also invests a substantial portion of its assets in below investment-grade senior loans and other below investment-grade assets.

The Trust invests in sectors, such as healthcare, education and childcare; cable; chemicals, plastics and rubber; utilities; printing and publishing; leisure, amusement and entertainment; oil and gas; retail stores; data and Internet services, and beverage, food and tobacco. The Trust�� investment advisor is ING Investments, LLC. ING Prime Rate Trust�� sub-advisor is ING Investment Management Co. and its administrator is ING Funds Services, LLC. ING Investments, LLC, ING Investment Management Co. and ING Funds Services, LLC are indirect, wholly owned subsidiaries of ING Groep N.V.

Advisors' Opinion:

• [By John Dowdee]

  The following 10 funds satisfied all of these conditions:

  BlackRock Float Rate Strategies (FRA). This CEF sells at a discount of 3%, which is low compared to an average premium of 2% over the past year. The distribution has been managed at 6.1% and a small amount (less than 10%) has been return of capital (ROC). However, this has not negatively affected net asset value (NAV) so has not been destructive. The fund holds 447 securities, with 90% in floating rate loans. FRA utilizes 27% leverage and has an expense ratio of 1.7%, including interest payments. Eaton Vance Floating Rate (EFR). This CEF sells at a 1% premium, which is low compared to an average premium of 5% over the past year. The distribution is 6.2%, none of which was ROC. The fund holds 800 securities, with 90% in floating rate loans. About 85% of the securities are from U.S. companies. EFR utilizes 35% leverage and has an expense ratio of 1.8% including interest payments. ING Prime Rate Trust (PPR). This CEF sells for a premium of 2%, which is below the average premium of 5%. It has a distribution of 6.8%, none of which was ROC. The fund has 350 holdings, virtually all in senior loans and from US companies. PPR utilizes 29% leverage and has a high expense ratio of 2.1%, including interest payments. Invesco VK Dynamic Credit Opportunities (VTA). This CEF sells for a discount of 5%, which is below the average discount of 1%. It has a distribution of 7.1%, none of which was ROC. The fund has 495 holdings, with 76% in floating rate loans. About 25% of the loans are from non-US companies. VTA utilizes a relatively low 20% leverage but still has a high expense ratio of 2.1%, including interest payments. Invesco VK Senior Income (VVR). This CEF sells for a discount of 1%, which is below the average premium of 3%. It has a distribution of 7.1%, none of which was ROC. The fund has over 500 holdings, with 89% in floating rate loans. Almost all (95%) securities are from US companies. VVR ut
• [By Aaron Levitt]

  The main reason why investors fled bounds during the taper tantrum is that bond prices have a negative correlation with rising interest rates. The ING Prime Rate Trust (PPR) avoids some of those problems.

Top 10 Diversified Bank Companies To Own For 2014: Track Data Corp (TRAC)

Track Data Corporation is a financial services company that provides real-time financial market data, fundamental research, charting and analytical services to institutional and individual investors through telecommunication lines and the Internet. The Company also disseminates news and third-party database information from approximately 100 sources worldwide. The Company operates in three segments: professional market, which provides market data services and trading, including electronic communications network (ECN) services, to the institutional professional investment community; non-professional market, which includes Internet-based online trading and market data services to the non-professional individual investor community, and arbitrage trading. Its wholly owned subsidiary, Track Data Securities Corp. (TDSC) is a registered securities broker-dealer. Track Data provides an integrated Internet-based online trading and market data system, proTrack, for the professional institutional traders, and myTrack and myTrack Edge, for the individual trader. It operates Track ECN, an ECN that enables traders to display and match limit orders for stocks.

Professional Market

MarkeTrack provides domestic and international market information, updating quotelines, options and futures displays, real-time spreadsheets, tick-by-tick updating graphics, news services and third-party databases, user-defined screen layouts, access to back-office order and execution services. The solution allows users to calculate theoretical values of options and determine the most beneficial investment strategy through calculating returns on alternative investments, including options and futures. MarkeTrack serves approximately 700 customers in trading and institutional investment management positions. Customers include floor traders, block traders, market makers, over the counter (OTC) traders, options specialists, head traders, arbitrageurs and hedge fund managers.

The Company offers proTrack ! as a direct access trading system for the professional market. Among the trading features offered by proTrack are point and click equities and options trading, direct access to market makers and ECNs, hot keys, smart order routing, reserve book, quick modification of existing orders, multiple order types and a variety of market data and news. proTrack offers trading through TDSC and clearing through Penson Financial Services, Inc. It is also available for use by other broker dealers under a service bureau arrangement.

TDSC operates an ECN that enables traders to display and match limit orders for stocks. The ECN allows trading of National Association of Securities Dealers Automated Quotation (Nasdaq) Global Market, Nasdaq Capital Market, New York Stock Exchange (NYSE) and American Stock Exchange (AMEX) listed securities, and exchange-listed securities on its platform. Track ECN displays orders on the National Stock Exchange (NSX). Track Data Corporation's NewsWatch service includes a consolidated news ticker, including database with text indexing and access to a variety of third-party databases.

The Company competes with Bloomberg Financial, Thomson/Reuters Group, Goldman Sachs, Lehman Brothers, Inc., Lava, Inc., Acquire Media, NYSE, Nasdaq, DirectEdge and BATS.

Non-Professional Market

Track Data offers Internet-based online trading and market data services through its myTrack and myTrack Edge products. myTrack and myTrack Edge offer trading of United States-based stocks, options and mutual funds, as well as stock index-based futures. For those traders who are the most active and engage in day trading, the myTrack Pro contains multi windows-based features and enhancements that are designed to satisfy the needs of the trader community. myTrack Edge provides access to information on stocks, options, indices, and news, including bid and ask prices, charts, research and other information for any listed or Nasdaq-traded stock and numerous over-the-counte! r bulleti! n board (OTC-BB) stocks, as well as the ability to establish and track securities, cash, margin and buying power positions on a real-time basis. Real-time quotes, news, charting and technical analysis are available in various pay packages. Volume trading can result in rebates equivalent to the service plan charges.

The Company also offers AIQ Systems and Dial/Data Service. AIQ Systems develops and markets artificial intelligence (AI) based stock market analysis and charting software for personal computers. By simulating the reasoning of top market technicians, AIQ's Expert Systems delivers trading signals and market insight, as well as advanced technical charting and screening capabilities. Dial/Data is an Internet-based service that provides historical and end-of-day pricing data for United States, Canadian and European exchange-traded equities and related instruments, futures, equity options, futures options, mutual funds, bonds, government issues, money markets and indexes.

The Company competes with E*Trade Group, Inc., Trade Station Group, Inc., Charles Schwab & Co., Inc., Options Express, TD Ameritrade, Inc., e-Signal, DTN, AT Financial, Data Corp., The Dow Jones Retrieval Service, Compuserve, Telescan, Commodity Systems, Inc., Equis International, Windows on Wall Street and Omega.

Arbitrage Trading

The Company engages in arbitrage trading activity. Its trading strategy consists principally of establishing hedged positions consisting of stocks and options. The Company also engages in options trading. The Company's trading strategy consists of selling short deep out-of-the-money calls and puts.

Advisors' Opinion:

• [By Bill Smith]

  FDS operates in a highly competitive industry, some with more resources. Their competitors include:
  Thomson Reuters Corp. (TRI)BloombergInteractive (IDC)MSCI Inc. (MXB)Morningstar Inc. (MORN)Track Data Corp. (TRAC)Edgar Online (EDGR)McGraw-Hill (MHP )